Generic Spiriva Delivers First Mover Advantage In US, Lupin Plans Europe Launch

Lucentis Biosimilar Filing Seen In FY25

 
• By Vibha Ravi
  
Growth Upward Trajectory
Lupin - On A Growth Trajectory • Source: Shutterstock

More from Strategy

More from Business